James Paul Burnett, Jr

Title: Innovations of James Paul Burnett, Jr.

Introduction

James Paul Burnett, Jr. is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of glutamate receptors. With a total of 3 patents to his name, Burnett's work has implications for understanding human neurological functions.

Latest Patents

One of his latest patents is titled "Isolated nucleic acid encoding a human mGluR5." This invention describes two novel human glutamate receptors, designated mGluR5A and mGluR5B. The patent encompasses nucleic acids encoding this receptor, or a fragment thereof, as well as methods employing this receptor and the nucleic acid compounds. Another significant patent is "Excitatory amino acid receptor protein expression testing methods." This invention describes a novel human glutamate receptor, designated mGluR2. Similar to his previous work, this patent also includes nucleic acids encoding this receptor, or a fragment thereof, along with methods for utilizing this receptor and the nucleic acid compounds.

Career Highlights

James Paul Burnett, Jr. is currently associated with Eli Lilly and Company, where he continues to innovate and contribute to advancements in medical science. His work at Eli Lilly has positioned him as a key player in the development of therapeutic solutions.

Collaborations

Throughout his career, Burnett has collaborated with esteemed colleagues, including Nancy G Mayne and Robert L Sharp. These collaborations have further enriched his research and development efforts.

Conclusion

James Paul Burnett, Jr. stands out as an influential inventor in the field of biotechnology. His patents and ongoing work at Eli Lilly and Company reflect his commitment to advancing scientific knowledge and improving human health.